Skip to main content
Equibles

David Jin

CFO

Avenue Therapeutics, Inc. (ATXI)

Equibles does not estimate personal net worth.

Get an email with a short summary when Avenue Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATXI alerts

About David Jin

David Jin is recorded as CFO at Avenue Therapeutics, Inc. (ATXI). The newest filing on record that lists David Jin as CFO at Avenue Therapeutics, Inc. (ATXI) is dated December 5, 2025. David Jin was last confirmed as CEO and Board Member at Change Agents Corporation. (CHGA) in a filing dated November 14, 2025. Change Agents Corporation. reported in an 8-K filed October 13, 2023 that David Jin was appointed director, effective October 12, 2023. Avenue Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avenue Therapeutics, Inc. includes Alexandra MacLean (CEO and Board Member), Alexandra MacLean, M.D. (CEO and Board Member), Jay Kranzler, M.D., Ph.D. (Chairman and Board Member) and 7 others.

“The following directors were elected to serve on the board of directors of the Company (the "Board"):”
Change Agents Corporation. Form 8-K, filed October 13, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Avenue Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Avenue Therapeutics, Inc. (ATXI) — —
2021 Avenue Therapeutics, Inc. (ATXI) — —

Recent activity